Perkins Capital Management Inc Axogen, Inc. Transaction History

Perkins Capital Management Inc

$104 Million
Q4 2024

A detailed history of Perkins Capital Management Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 261,224 shares of AXGN stock, worth $4.55 Million. This represents 4.15% of its overall portfolio holdings.

Number of Shares

261,224

Previous 283,399 7.82%

Holding current value

$4.55 Million

Previous $3.97 Million 8.33%

% of portfolio

4.15%

Previous 3.91%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 11, 2025	SELL	$12.47 - $17.19 $276,522 - $381,188	-22,175 Reduced 7.82%	261,224 $4.3 Million
Q3 2024 Oct 31, 2024	SELL	$7.52 - $14.69 $44,744 - $87,405	-5,950 Reduced 2.06%	283,399 $3.97 Million
Q2 2024 Aug 09, 2024	SELL	$5.67 - $8.06 $48,762 - $69,316	-8,600 Reduced 2.89%	289,349 $2.09 Million
Q1 2024 May 09, 2024	SELL	$6.63 - $10.69 $11,045 - $17,809	-1,666 Reduced 0.56%	297,949 $2.4 Million
Q4 2023 Jan 22, 2024	SELL	$3.61 - $7.76 $6,227 - $13,386	-1,725 Reduced 0.57%	299,615 $2.05 Million
Q3 2023 Nov 02, 2023	BUY	$4.68 - $9.26 $11,466 - $22,687	2,450 Added 0.82%	301,340 $1.51 Million
Q2 2023 Jul 21, 2023	SELL	$8.5 - $10.38 $90,100 - $110,028	-10,600 Reduced 3.42%	298,890 $2.73 Million
Q1 2023 May 09, 2023	BUY	$7.53 - $10.95 $18,448 - $26,827	2,450 Added 0.8%	309,490 $2.93 Million
Q4 2022 Jan 26, 2023	BUY	$9.44 - $13.09 $3,776 - $5,236	400 Added 0.13%	307,040 $3.06 Million
Q3 2022 Oct 24, 2022	BUY	$8.14 - $12.25 $5,698 - $8,575	700 Added 0.23%	306,640 $3.66 Million
Q2 2022 Jul 29, 2022	BUY	$6.99 - $10.0 $124,072 - $177,500	17,750 Added 6.16%	305,940 $2.51 Million
Q1 2022 Apr 20, 2022	BUY	$7.26 - $10.7 $79,860 - $117,699	11,000 Added 3.97%	288,190 $2.29 Million
Q4 2021 Feb 10, 2022	BUY	$8.8 - $16.0 $34,760 - $63,200	3,950 Added 1.45%	277,190 $2.6 Million
Q3 2021 Oct 25, 2021	BUY	$15.23 - $21.72 $6,092 - $8,688	400 Added 0.15%	273,240 $4.32 Million
Q2 2021 Jul 28, 2021	SELL	$17.8 - $23.5 $82,770 - $109,275	-4,650 Reduced 1.68%	272,840 $5.9 Million
Q4 2020 Feb 09, 2021	SELL	$11.5 - $17.96 $100,050 - $156,252	-8,700 Reduced 3.04%	277,490 $4.97 Million
Q3 2020 Oct 28, 2020	SELL	$10.62 - $13.12 $127,970 - $158,096	-12,050 Reduced 4.04%	286,190 $3.33 Million
Q1 2020 Apr 29, 2020	BUY	$8.38 - $17.34 $12,151 - $25,143	1,450 Added 0.49%	298,240 $3.1 Million
Q4 2019 Feb 03, 2020	SELL	$11.18 - $18.6 $256,972 - $427,521	-22,985 Reduced 7.19%	296,790 $5.31 Million
Q3 2019 Oct 23, 2019	SELL	$12.09 - $20.46 $241,800 - $409,200	-20,000 Reduced 5.89%	319,775 $3.99 Million
Q2 2019 Aug 09, 2019	SELL	$18.5 - $25.47 $172,975 - $238,144	-9,350 Reduced 2.68%	339,775 $6.73 Million
Q1 2019 Apr 22, 2019	SELL	$14.62 - $22.13 $103,071 - $156,016	-7,050 Reduced 1.98%	349,125 $7.35 Million
Q4 2018 Feb 11, 2019	SELL	$17.09 - $38.25 $48,279 - $108,056	-2,825 Reduced 0.79%	356,175 $7.28 Million
Q3 2018 Oct 22, 2018	SELL	$34.05 - $55.9 $227,283 - $373,132	-6,675 Reduced 1.83%	359,000 $13.2 Million
Q2 2018 Aug 02, 2018	SELL	$36.15 - $52.5 $2.26 Million - $3.29 Million	-62,575 Reduced 14.61%	365,675 $18.4 Million
Q1 2018 Apr 23, 2018	SELL	$24.4 - $40.25 $1.61 Million - $2.65 Million	-65,900 Reduced 13.34%	428,250 $15.6 Million
Q4 2017 Jan 26, 2018	SELL	$18.5 - $28.6 $840,788 - $1.3 Million	-45,448 Reduced 8.42%	494,150 $14 Million
Q3 2017 Oct 31, 2017	BUY	$14.65 - $19.35 $7.91 Million - $10.4 Million	539,598	539,598 $10.4 Million

Others Institutions Holding AXGN

# of Institutions

179

Shares Held

36.2M

Call Options Held

82.6K

Put Options Held

1.1K

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $737M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account

Perkins Capital Management Inc Axogen, Inc. Transaction History